Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $3.8 million.

  • IceCure Medical's Income from Continuing Operations fell 1064.52% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.4 million, marking a year-over-year increase of 560.13%. This contributed to the annual value of $15.7 million for FY2024, which is 77.04% up from last year.
  • Per IceCure Medical's latest filing, its Income from Continuing Operations stood at $3.8 million for Q3 2025, which was down 1064.52% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's Income from Continuing Operations peaked at $4.5 million during Q4 2024, and registered a low of -$29.5 million during Q4 2022.
  • Over the past 5 years, IceCure Medical's median Income from Continuing Operations value was $3.7 million (recorded in 2025), while the average stood at $806789.5.
  • As far as peak fluctuations go, IceCure Medical's Income from Continuing Operations tumbled by 12976.21% in 2021, and later skyrocketed by 33379.31% in 2022.
  • Over the past 5 years, IceCure Medical's Income from Continuing Operations (Quarter) stood at -$16.3 million in 2021, then crashed by 81.04% to -$29.5 million in 2022, then skyrocketed by 111.56% to $3.4 million in 2023, then skyrocketed by 32.5% to $4.5 million in 2024, then fell by 15.23% to $3.8 million in 2025.
  • Its Income from Continuing Operations was $3.8 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.7 million in Q1 2025.